[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349147-105":59,"doc-detail-349147-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","non-coding-rnas-modulators-of-signaling-pathways-and-prognostic-biomarkers-in-digestive-system-cancer","Non-coding RNAs - Modulators of Signaling Pathways and Prognostic Biomarkers in Digestive System Cancer","","Digestive system cancer remains among the most lethal aggressive cancers, with poor patient survival largely driven by late detection and rapid disease progression. This review consolidates current evidence on non-coding RNAs (ncRNAs) and their mechanistic roles in digestive system cancer, emphasizing how ncRNAs regulate key signaling pathways, including Wnt/β-catenin and PI3K/AKT. It also evaluates their functions in tumor proliferation, invasion, immune microenvironment remodeling, glycolytic metabolism, and macrophage polarization, while summarizing prognostic biomarker potential and future intervention relevance for precision medicine.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/non-coding-rnas-modulators-of-signaling-pathways-and-prognostic-biomarkers-in-digestive-system-cancer/349147/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/non-coding-rnas-modulators-of-signaling-pathways-and-prognostic-biomarkers-in-digestive-system-cancer/349147.png","ImageObject",300,407,{"name":92,"@type":93},"Nguyễn Văn Học","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is digestive system cancer associated with poor survival?","Question",{"text":113,"@type":114},"Late detection and rapid disease progression limit treatment effectiveness and contribute to low survival expectations. Advanced-stage cases remain difficult to control despite improved therapies.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which signaling pathways does ncRNA modulate in digestive system cancer?",{"text":118,"@type":114},"The review highlights modulation of Wnt/β-catenin and PI3K/AKT pathways. These changes connect ncRNA activity to multiple downstream processes in cancer development.",{"name":120,"@type":111,"acceptedAnswer":121},"How can ncRNAs contribute to prognosis and targeted therapy?",{"text":122,"@type":114},"The review summarizes evidence that ncRNAs have prognostic significance in digestive system cancers. It also frames ncRNAs as potential biological markers and intervention targets that may advance precision medicine.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349147,1790789898,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Chen et al. Molecular Cancer (2026) 25:128 [https://doi.org/10.1186/s12943-025-02549-7](https://doi.org/10.1186/s12943-025-02549-7)  \nMolecular Cancer  \nREVIEW Open Access  \nNon-coding RNAs: modulators of signaling pathways and prognostic biomarkers in digestive system cancer  \nGuoming Chen1, Yinglan Liang2, Ying Yan3, Jiayi Zou4, Jiayi Zhang4, Xiaotong Zeng5, Liangman Xiao4, Cheng Zhang1 and Yibin Feng1,6*  \nAbstract  \nDigestive system cancer is one of the most lethal forms of aggressive cancer in the world. Although diagnosis and treatment methods have improved, most patients have poor survival expectations due to late detection and rapid disease progress. Some recent studies have delved into the molecular level of the mechanism of non-coding RNA (ncRNA) intervention in digestive system cancer and have conducted a more in-depth and comprehensive discussion. At the same time, it has also been shown that ncRNA plays an important role in early detection and targeted treatment of digestive system cancer. This review summarizes the roles of ncRNAs in modulating multiple key pathways, including Wnt/β-catenin and PI3K/AKT, thereby influencing diverse processes such as tumor proliferation, invasion, immune microenvironment remodeling, glycolytic metabolism, and macrophage polarization. Additionally, the prognostic significance of ncRNAs in digestive system cancers is summarized and appraised. According to the current review, ncRNA is expected to become a potential biological marker and intervention target for digestive system cancer, helping the treatment of digestive system cancer to move further towards precision medicine.  \nKeywords Digestive system cancer, Non-coding RNAs, Signaling pathways, Prognostic biomarkers  \n*Correspondence:  \nYibin Feng  \nyfeng@hku.hk  \n1School of Chinese Medicine, The University of Hong Kong, Hong Kong S.A. R., China, Hong Kong S.A. R., China  \n2The Second School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China  \n3The School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China  \n4The First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China  \n5The Fourth School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China  \n6Li Ka Shing Faculty of Medicine, School of Chinese Medicine, The University of Hong Kong, Hong Kong SAR, China  \nIntroduction  \nDigestive system cancer is one of the most invasive cancer deaths in the world [1]. DSC mainly include esophageal cancer (EC), gastric cancer (GC), hepatocellular carcinoma (HCC), colorectal cancer (CRC), pancreatic cancer (PC), etc. According to statistics, it caused > 4.8 million new cases and about 3.5 million deaths worldwide in 2022[2]. This not only causes physical and mental pain to the patient, but also brings a heavy economic burden to the family and society. According to statistics, during the period from 2003 to 2013, the cost of clinical diagnosis and treatment of GC patients in China increased from 18,504 to 41,871, with an average annual growth rate of 5.5%[3]. Although surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, etc. are currently  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Com","cbCaigwhGyjlursx","https://ap.wps.com/l/cbCaigwhGyjlursx","pdf",2391899,22,"English","# Abstract\n# Introduction\n## Digestive system cancer burden and clinical challenges\n## ncRNA types and regulatory mechanisms\n## Relevance to pathways and malignancy progression","[{\"question\":\"Why is digestive system cancer associated with poor survival?\",\"answer\":\"Late detection and rapid disease progression limit treatment effectiveness and contribute to low survival expectations. Advanced-stage cases remain difficult to control despite improved therapies.\"},{\"question\":\"Which signaling pathways does ncRNA modulate in digestive system cancer?\",\"answer\":\"The review highlights modulation of Wnt/β-catenin and PI3K/AKT pathways. These changes connect ncRNA activity to multiple downstream processes in cancer development.\"},{\"question\":\"How can ncRNAs contribute to prognosis and targeted therapy?\",\"answer\":\"The review summarizes evidence that ncRNAs have prognostic significance in digestive system cancers. It also frames ncRNAs as potential biological markers and intervention targets that may advance precision medicine.\"}]","Non-coding RNAs - Modulators of Signaling Pathways and Prognostic Biomarkers in Digestive System Cancer | PDF",1790081953,55,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2db86845531ef3093e91ecb81c0c9a7.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d90dec01eb78a649312895342888634.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67d93fabf906b5fb8111a478fcea19f5.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb709f27802ac0849a34bb90d0b0aacf.webp",980,1306]